Related Articles
c-erbB-2 status is an independent predictor of survival after first recurrence.
Relative effects of immunohistochemical expressions of c-erbB-2, p53, and bcl-2 oncoproteins on the survival of advanced breast cancer patients after endocrine therapy
PROGNOSTIC VALUE OF P53 EXPRESSION IN EARLY-STAGE BREAST-CARCINOMA COMPARED WITH TUMOR ANGIOGENESIS, EPIDERMAL GROWTH-FACTOR RECEPTOR, C-ERBB-2, CATHEPSIN-D, DNA-PLOIDY, PARAMETERS OF CELL-KINETICS AND CONVENTIONAL FEATURES
HELIX-POMATIA LECTIN AND C-ERBB-2 EXPRESSION VERSUS AXILLARY AND INTERNAL MAMMARY LYMPH-NODE METASTASES IN PROGNOSTIC ASSESSMENT OF BREAST-CANCER
Clinical significance of serum c-erbB-2 protein in patients with primary breast cancer